Medical Imaging Partnership and Prime Health secure funding

Medical Imaging Partnership and Prime Health

Medical Imaging Partnership and Prime Health, part of Imaging Holdings, have secured a significant funding facility from private equity firm Apposite Capital to support expansion of their diagnostic services. Medical Imaging Partnership acquired Prime Health in 2018.

The investment will support four additional mobile MRI and CT platforms, additional funding for an advanced CT platform at the Weybridge location, and investment in the MRI service capability at the central London site, all to be delivered this year.

Medical Imaging Partnership and Prime Health participate in 24 NHS frameworks and agreements including the NHS Increasing Capacity Framework, the NHS Supply Chain Framework, and the NHS Shared Business Services framework for outsourced services. The company’s services include diagnostic pathways and other health services for patients with cancer, musculoskeletal disorders, and cardiac conditions.

Medical Imaging Partnership and Prime Health operate in the Surrey, Sussex, Kent, London and Manchester areas and backing by Apposite dates from 2016. Over the past two years the companies have expanded services in diagnostics, primary care, and sub-specialty consulting.

Imaging Holdings’ group chief executive Andrew Lennox said: “This is a very exciting time for the company; we have significant plans for the future for both continued support of the NHS intra and post-Covid at our ‘cold-Covid’ locations, and also in growth of our private clinics. This first investment further underpins our leading position focusing on innovative delivery models of imaging diagnostic in the community. We look to support the roll out of the Richard Review and GIRFT Report findings and launch additional services to support the wider UK health market.”

Imaging Holdings’ group chief medical officer Dr Paul Zollinger-Read added: “Our existing network of sites across the UK have supported over 40,000 patients through this past year, and the addition of these advanced platforms will allow our clinicians to reach more people and deliver a greater range of services than ever before. The need in the UK for access to rapid and accurate diagnostic and clinical services has never been greater, and our vision to make a difference to people’s lives takes a significant step forward with this investment.”

Date published: April 1, 2021

Subscriber content

To get unlimited access subscribe today


Already a subscriber? Login